DiaMedica Therapeutics Inc. Contracts & Agreements
68 Contracts & Agreements
- Business Finance (24 contracts)
- Business Operations (14)
- Human Resources (19)
- Real Estate (6)
- Uncategorized (5)
- Form of Securities Purchase Agreement, dated as of June 25, 2024, by and among DiaMedica Therapeutics Inc. and the Purchasers Party Thereto (Filed With SEC on June 26, 2024)
- Form of Registration Rights Agreement by and among DiaMedica Therapeutics Inc. and the Purchasers Party Thereto (Filed With SEC on June 26, 2024)
- DiaMedica Therapeutics Inc. Amended and Restated Omnibus Incentive Plan (Effective May 22, 2024) (Filed With SEC on May 23, 2024)
- Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 19, 2024)
- Third Amendment to GPEx Development and Manufacturing Agreement dated as of April 11, 2022 between DiaMedica Therapeutics Inc. and Catalent Pharma Solutions, LLC (Filed With SEC on March 19, 2024)
- Consulting Services Agreement dated as of September 1, 2023 by and between Kirsten Gruis, M.D. and DiaMedica USA, Inc (Filed With SEC on September 5, 2023)
- Separation Agreement and Release dated as of September 3, 2023 by and between Kirsten Gruis, M.D. and DiaMedica USA, Inc (Filed With SEC on September 5, 2023)
- Form of Securities Purchase Agreement, dated as of June 21, 2023, by and among DiaMedica Therapeutics Inc. and the Purchasers Party Thereto (Filed With SEC on June 21, 2023)
- Form of Registration Rights Agreement by and among DiaMedica Therapeutics Inc. and the Purchasers Party Thereto (Filed With SEC on June 21, 2023)
- Employment Agreement effective as of January 3, 2022 between DiaMedica USA, Inc. and Kirsten Gruis (Filed With SEC on March 28, 2023)
- 301 Carlson Parkway Office Lease dated June 22, 2022 between Medica Services Company, LLC and DiaMedica USA Inc (Filed With SEC on June 29, 2022)
- Lease Guaranty Agreement dated June 22, 2022 by DiaMedica Therapeutics Inc (Filed With SEC on June 29, 2022)
- Separation Agreement and Release dated as of May 23, 2022 by and between Harry Alcorn, Jr. Pharm.D. and DiaMedica USA, Inc (Filed With SEC on May 25, 2022)
- Consulting Services Agreement dated as of May 23, 2022 by and between Harry Alcorn, Jr. Pharm.D. and DiaMedica USA, Inc (Filed With SEC on May 25, 2022)
- DiaMedica Therapeutics Inc. Amended and Restated 2019 Omnibus Incentive Plan (Filed With SEC on May 19, 2022)
- Form of Option Award Agreement under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan (Filed With SEC on March 14, 2022)
- DiaMedica Therapeutics Inc. 2021 Employment Inducement Incentive Plan (Filed With SEC on March 14, 2022)
- Form of Inducement Option Award Agreement under the DiaMedica Therapeutics Inc. 2021 Employment Incentive Plan (Filed With SEC on March 14, 2022)
- Securities Purchase Agreement, dated as of September 26, 2021, by and among DiaMedica Therapeutics Inc. and the purchasers party thereto (Filed With SEC on September 27, 2021)
- Form of Registration Rights Agreement by and among DiaMedica Therapeutics Inc. and the purchasers party thereto (Filed With SEC on September 27, 2021)
- Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 10, 2021)
- Warrant dated September 11, 2020 issued by DiaMedica Therapeutics Inc. to Craig-Hallum Capital Group LLC (Filed With SEC on November 4, 2020)
- Form of Deferred Stock Unit Award Agreement under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan (Filed With SEC on August 11, 2020)
- Underwriting Agreement, dated August 6, 2020, by and between DiaMedica Therapeutics Inc. and Guggenheim Securities, LLC (Filed With SEC on August 10, 2020)
- Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 23, 2020)
- Warrant dated October 1, 2019 issued by DiaMedica Therapeutics Inc. to Craig-Hallum Capital Group LLC (Filed With SEC on March 23, 2020)
- Second Amendment to GPEx Development and Manufacturing Agreement dated as of October 22, 2018 between DiaMedica Therapeutics Inc. and Catalent Pharma Solutions, LLC (Filed With SEC on March 23, 2020)
- Underwriting Agreement, dated February 11, 2020, by and between DiaMedica Therapeutics Inc. and Craig-Hallum Capital Group LLC (Filed With SEC on February 13, 2020)
- Litigation Funding Agreement, dated as of December 27, 2019, between LEGALIST FUND II, L.P. and DiaMedica Therapeutics Inc (Filed With SEC on January 3, 2020)
- DiaMedica Therapeutics Inc. Short-Term Incentive Plan (Filed With SEC on June 21, 2019)
- Form of Option Award Agreement under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan (Filed With SEC on June 21, 2019)
- Form of Restricted Stock Unit Award Agreement under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan (Filed With SEC on June 21, 2019)
- Specimen Certificate representing Voting Common Shares of DiaMedica Therapeutics Inc (Filed With SEC on June 4, 2019)
- Form of Indemnification Agreement between DiaMedica Therapeutics Inc. and each Director and Officer (Filed With SEC on June 4, 2019)
- DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan (Filed With SEC on May 23, 2019)
- Employment Agreement by and between DiaMedica Therapeutics Inc. and Scott Kellen (Filed With SEC on March 19, 2019)
- Employment Agreement by and between DiaMedica Therapeutics Inc. and Harry Alcorn, Ph.D (Filed With SEC on March 19, 2019)
- Underwriting Agreement dated December 6, 2018 between Craig-Hallum Capital Group LLC and DiaMedica Therapeutics Inc (Filed With SEC on December 11, 2018)
- Warrant dated December 11, 2018 issued by DiaMedica Therapeutics Inc. to Craig-Hallum Capital Group LLC (Filed With SEC on December 11, 2018)
- Form of Underwriting Agreement (Filed With SEC on November 27, 2018)
- Form of Underwriters Warrant (Filed With SEC on November 27, 2018)
- Specimen Certificate representing common shares of DiaMedica Therapeutics Inc (Filed With SEC on November 19, 2018)
- Investment Agreement between Hermeda Industrial Co., Ltd. and DiaMedica Inc. dated July 16, 2016 (Filed With SEC on November 9, 2018)
- Shareholder Rights Plan Agreement dated December 21, 2017 by and between DiaMedica Therapeutics Inc. and Computershare Investor Services Inc (Filed With SEC on November 9, 2018)
- Voting Agreement between Rick Pauls and DiaMedica Inc. dated July 2016 (Filed With SEC on November 9, 2018)
- Voting Agreement between Werner Pauls and DiaMedica Inc. dated July 2016 (Filed With SEC on November 9, 2018)
- Voting Agreement between Chris Pauls and DiaMedica Inc. dated July 2016 (Filed With SEC on November 9, 2018)
- Voting Agreement between Michael Giuffre, M.D. and DiaMedica Inc. dated July 2016 (Filed With SEC on November 9, 2018)
- Voting Agreement between Stephen Mullie and DiaMedica Inc. dated July 20, 2016 (Filed With SEC on November 9, 2018)
- Voting Agreement between J. Roderick Matheson and DiaMedica Inc. dated July 20, 2016 (Filed With SEC on November 9, 2018)
- Form of Investor Warrant issued in connection with the March 2018 private placement (Filed With SEC on November 9, 2018)
- Form of Broker Warrant issued in connection with the March 2018 private placement (Filed With SEC on November 9, 2018)
- Form of Investor Warrant issued in connection with the December 2017 private placement (Filed With SEC on November 9, 2018)
- DiaMedica Therapeutics Inc. Stock Option Plan Amended and Restated November 6, 2018 (Filed With SEC on November 9, 2018)
- Form of Option Agreement under the DiaMedica Therapeutics Inc. Stock Option Plan Amended and Restated December 21, 2017 (Filed With SEC on November 9, 2018)
- Form of Option Agreement under the DiaMedica Therapeutics Inc. Stock Option Plan Amended and Restated November 6, 2018 (Filed With SEC on November 9, 2018)
- DiaMedica Therapeutics Inc. Amended and Restated Deferred Share Unit Plan (Filed With SEC on November 9, 2018)
- Form of Indemnification Agreement (Filed With SEC on November 9, 2018)
- Employment Agreement by and between DiaMedica Therapeutics Inc. and Rick Pauls (Filed With SEC on November 9, 2018)
- Employment Agreement by and between DiaMedica Therapeutics Inc. and Todd Verdoorn, Ph.D (Filed With SEC on November 9, 2018)
- Two Carlson Parkway Office Lease between One Two Holdings LLC and DiaMedica USA Inc. dated September 18, 2015 (Filed With SEC on November 9, 2018)
- Supplemental to Lease Agreement between One Two Holdings LLC and DiaMedica USA Inc. dated December 16, 2015 (Filed With SEC on November 9, 2018)
- First Amendment to Lease between One Two Holdings LLC and DiaMedica USA Inc. dated May 3, 2017 (Filed With SEC on November 9, 2018)
- Second Amendment to Lease between One Two Holdings LLC and DiaMedica USA Inc. dated September 5, 2017 (Filed With SEC on November 9, 2018)
- GPEx - Derived Cell Line Sale Agreement between DiaMedica Therapeutics Inc. and Catalent Pharma Solutions, LLC dated February 2, 2012 (Filed With SEC on November 9, 2018)
- First Amendment to GPEx Development and Manufacturing Agreement between DiaMedica Therapeutics Inc. and Catalent Pharma Solutions, LLC dated April 10, 2017 (Filed With SEC on November 9, 2018)
- License and Collaboration Agreement between DiaMedica Therapeutics Inc. and Ahon Pharmaceutical Co., Ltd. dated September 27, 2018 (Filed With SEC on November 9, 2018)
- Supply Agreement between DiaMedica Therapeutics Inc. and Ahon Pharmaceutical Co., Ltd. dated September 27, 2018 (Filed With SEC on November 9, 2018)
